Inherited human OX40 deficiency underlying classic Kaposi sarcoma of childhood

Human OX40 is necessary for robust CD4+ T cell memory and confers selective protective immunity against HHV-8 infection in endothelial cells.

[1]  Charles M. Rice,et al.  Corrigendum: A diverse range of gene products are effectors of the type I interferon antiviral response , 2015, Nature.

[2]  N. Tuzuner,et al.  Classic kaposi sarcoma with pulmonary involvement mimicking endobronchial tuberculosis in a child , 2013, Pediatric pulmonology.

[3]  C. Papadopoulos,et al.  OX40-OX40L expression in idiopathic inflammatory myopathies , 2013, Journal of the Neurological Sciences.

[4]  M. Croft,et al.  OX40 Facilitates Control of a Persistent Virus Infection , 2012, PLoS pathogens.

[5]  R. Kumar,et al.  Immunobiology of visceral leishmaniasis , 2012, Front. Immun..

[6]  Antonio Lanzavecchia,et al.  Functionally distinct subsets of human FOXP3+ Treg cells that phenotypically mirror effector Th cells. , 2012, Blood.

[7]  V. Lougaris,et al.  Expansion of somatically reverted memory CD8+ T cells in patients with X-linked lymphoproliferative disease caused by selective pressure from Epstein-Barr virus , 2012, The Journal of experimental medicine.

[8]  K. Schwarz,et al.  Antiviral and Regulatory T Cell Immunity in a Patient with Stromal Interaction Molecule 1 Deficiency , 2012, The Journal of Immunology.

[9]  N. Morris,et al.  Science gone translational: the OX40 agonist story , 2011, Immunological reviews.

[10]  S. Choo,et al.  Molecular Pathogenesis of EBV Susceptibility in XLP as Revealed by Analysis of Female Carriers with Heterozygous Expression of SAP , 2011, PLoS biology.

[11]  Hanan A. Salem,et al.  Kaposi’s Sarcoma in an Atopic Dermatitis Patient: A Case Report and a Review of Literature , 2011, Pediatric dermatology.

[12]  B. Ferruà,et al.  Importance of worldwide asymptomatic carriers of Leishmania infantum (L. chagasi) in human. , 2011, Acta tropica.

[13]  J. Goedert,et al.  Cancer burden in the HIV-infected population in the United States. , 2011, Journal of the National Cancer Institute.

[14]  J. Verbsky,et al.  Faculty Opinions recommendation of Revisiting human IL-12Rβ1 deficiency: a survey of 141 patients from 30 countries. , 2011 .

[15]  J. Casanova,et al.  Life‐threatening infectious diseases of childhood: single‐gene inborn errors of immunity? , 2010, Annals of the New York Academy of Sciences.

[16]  Smita Y. Patel,et al.  Revisiting Human IL-12R&bgr;1 Deficiency: A Survey of 141 Patients From 30 Countries , 2010, Medicine.

[17]  S. Tangye,et al.  Impaired Epstein-barr Virus–specific Cd8 Ϩ T-cell Function in X-linked Lymphoproliferative Disease Is Restricted to Slam Family–positive B-cell Targets Eplpqgqltay from Bzlf1 and Yplheqhgm from Ebna3a, the B*2705- Restricted Epitopes, Rriydliel from Ebna3c, Hrcqairkk from Ebna3b, Rrrwrrltv from Lmp2 , 2022 .

[18]  J. Casanova,et al.  Whole-exome sequencing-based discovery of STIM1 deficiency in a child with fatal classic Kaposi sarcoma , 2010, The Journal of experimental medicine.

[19]  M. DePristo,et al.  The Genome Analysis Toolkit: a MapReduce framework for analyzing next-generation DNA sequencing data. , 2010, Genome research.

[20]  D. Ganem KSHV and the pathogenesis of Kaposi sarcoma: listening to human biology and medicine. , 2010, The Journal of clinical investigation.

[21]  P. Bork,et al.  A method and server for predicting damaging missense mutations , 2010, Nature Methods.

[22]  M. Croft Control of immunity by the TNFR-related molecule OX40 (CD134). , 2010, Annual review of immunology.

[23]  J. Casanova,et al.  Classic Kaposi Sarcoma in 3 Unrelated Turkish Children Born to Consanguineous Kindreds , 2010, Pediatrics.

[24]  Sami Al-Hajjar,et al.  B cell–intrinsic signaling through IL-21 receptor and STAT3 is required for establishing long-lived antibody responses in humans , 2010, The Journal of experimental medicine.

[25]  Gonçalo R. Abecasis,et al.  The Sequence Alignment/Map format and SAMtools , 2009, Bioinform..

[26]  D. Campana,et al.  Primary B cell immunodeficiencies: comparisons and contrasts. , 2009, Annual review of immunology.

[27]  Magdalini Moutaftsi,et al.  OX40 Drives Protective Vaccinia Virus-Specific CD8 T Cells12 , 2008, The Journal of Immunology.

[28]  C. Lebbé,et al.  Kaposi sarcoma in transplantation. , 2008, Transplantation reviews.

[29]  Mahmoud R. Hussein Cutaneous and lymphadenopathic Kaposi’s sarcoma: a case report and review of literature , 2008, Journal of cutaneous pathology.

[30]  Y. Li,et al.  Cytokine-Mediated Regulation of Human B Cell Differentiation into Ig-Secreting Cells: Predominant Role of IL-21 Produced by CXCR5+ T Follicular Helper Cells1 , 2007, The Journal of Immunology.

[31]  R. Peeling,et al.  Visceral leishmaniasis: what are the needs for diagnosis, treatment and control? , 2007, Nature Reviews Microbiology.

[32]  C. Benedict,et al.  OX40 Costimulation Promotes Persistence of Cytomegalovirus-Specific CD8 T Cells: A CD4-Dependent Mechanism1 , 2007, The Journal of Immunology.

[33]  J. Casanova,et al.  Primary Immunodeficiencies: A Field in Its Infancy , 2007, Science.

[34]  O. Sanal,et al.  A case of interleukin-12 receptor beta-1 deficiency with recurrent leishmaniasis. , 2007, The Pediatric Infectious Disease Journal.

[35]  S. Hymowitz,et al.  The crystal structure of the costimulatory OX40-OX40L complex. , 2006, Structure.

[36]  A. Fischer,et al.  Kaposi’s sarcoma in a child with Wiskott-Aldrich syndrome , 2006, European Journal of Pediatrics.

[37]  K. Sugamura,et al.  During Viral Infection of the Respiratory Tract, CD27, 4-1BB, and OX40 Collectively Determine Formation of CD8+ Memory T Cells and Their Capacity for Secondary Expansion1 , 2005, The Journal of Immunology.

[38]  S. Franceschi,et al.  Risk of Kaposi's sarcoma and of other cancers in Italian renal transplant patients , 2005, British Journal of Cancer.

[39]  P. Kaye,et al.  Immunotherapy with OX40L‐Fc or anti‐CTLA‐4 enhances local tissue responses and killing of Leishmania donovani , 2004, European journal of immunology.

[40]  J. Casanova,et al.  HHV-8–associated Kaposi sarcoma in a child with IFNγR1 deficiency , 2004 .

[41]  A. Lemainque,et al.  A major susceptibility locus on chromosome 22q12 plays a critical role in the control of kala-azar. , 2003, American journal of human genetics.

[42]  M. Croft Co-stimulatory members of the TNFR family: keys to effective T-cell immunity? , 2003, Nature Reviews Immunology.

[43]  L. Abel,et al.  [Epidemiology of human herpes virus 8 (HHV-8) or the herpes virus associated with Kaposi's sarcoma (KSHV)]. , 2002, Pathologie-biologie.

[44]  A. Gessain,et al.  Épidémiologie du virus herpès humain 8 (HHV-8) ou virus herpès associé au sarcome de Kaposi (KSHV) : Herpès - Deuxième partie , 2002 .

[45]  A. Ferrari,et al.  Malignant vascular tumors in children and adolescents: a report from the Italian and German Soft Tissue Sarcoma Cooperative Group. , 2002, Medical and pediatric oncology.

[46]  Jonathan Scott Friedlaender,et al.  A Human Genome Diversity Cell Line Panel , 2002, Science.

[47]  E. Nicastri,et al.  Primary human herpesvirus 8 infection in immunocompetent children. , 2002, JAMA.

[48]  J. Bogart,et al.  Classic Kaposi's sarcoma associated with human herpesvirus 8 infection in a 13-year-old male: a case report. , 2001, Clinical cancer research : an official journal of the American Association for Cancer Research.

[49]  C. Boshoff,et al.  Epidemiology and pathogenesis of Kaposi's sarcoma-associated herpesvirus. , 2001, Philosophical transactions of the Royal Society of London. Series B, Biological sciences.

[50]  L. Kingsley,et al.  Primary human herpesvirus 8 infection generates a broadly specific CD8(+) T-cell response to viral lytic cycle proteins. , 2001, Blood.

[51]  C. Boshoff,et al.  Seroepidemiology and molecular epidemiology of Kaposi's sarcoma-associated herpesvirus among Jewish population groups in Israel. , 2001, Journal of the National Cancer Institute.

[52]  D. Trégouët,et al.  Human herpesvirus 8 transmission from mother to child and between siblings in an endemic population , 2000, The Lancet.

[53]  M. Croft,et al.  The OX40 Costimulatory Receptor Determines the Development of CD4 Memory by Regulating Primary Clonal Expansion1 , 2000, The Journal of Immunology.

[54]  A. Imura,et al.  Vascular endothelial cells provide T cells with costimulatory signals via the OX40/gp34 system , 2000, Journal of leukocyte biology.

[55]  Yuetsu Tanaka,et al.  CD134L Engagement Enhances Human B Cell Ig Production: CD154/CD40, CD70/CD27, and CD134/CD134L Interactions Coordinately Regulate T Cell-Dependent B Cell Responses1 , 2000, The Journal of Immunology.

[56]  S. Franceschi,et al.  Classic Kaposi sarcoma , 2000, Cancer.

[57]  R. Locksley,et al.  Robust B cell immunity but impaired T cell proliferation in the absence of CD134 (OX40). , 1999, Journal of immunology.

[58]  C. Elia,et al.  Expression of lymphocyte-endothelial receptor-ligand pairs, α4β7/MAdCAM-1 and OX40/OX40 ligand in the colon and jejunum of patients with inflammatory bowel disease , 1999, Gut.

[59]  H. Yousif,et al.  Kala-azar in a high transmission focus: an ethnic and geographic dimension. , 1999, The American journal of tropical medicine and hygiene.

[60]  M. Bachmann,et al.  OX40-deficient mice are defective in Th cell proliferation but are competent in generating B cell and CTL Responses after virus infection. , 1999, Immunity.

[61]  H. Murray Kala-azar as an AIDS-related opportunistic infection. , 1999, AIDS patient care and STDs.

[62]  E. Nicastri,et al.  High seroprevalence of antibodies to human herpesvirus-8 in Egyptian children: evidence of non-sexual transmission. , 1999 .

[63]  G. de Thé,et al.  Human herpesvirus 8 primary infection occurs during childhood in Cameroon, Central Africa , 1999, International journal of cancer.

[64]  E. Nicastri,et al.  High seroprevalence of antibodies to human herpesvirus-8 in Egyptian children: evidence of nonsexual transmission. , 1999, Journal of the National Cancer Institute.

[65]  S Hansen,et al.  Skin cancer in kidney and heart transplant recipients and different long-term immunosuppressive therapy regimens. , 1999, Journal of the American Academy of Dermatology.

[66]  L. Cuevas,et al.  Prevalence and transmission of Kaposi's sarcoma‐associated herpesvirus (human herpesvirus 8) in Ugandan children and adolescents , 1998, International journal of cancer.

[67]  P. Pellett,et al.  Human herpesvirus 6 , 1997, Clinical microbiology reviews.

[68]  Yuetsu Tanaka,et al.  The human OX40/gp34 system directly mediates adhesion of activated T cells to vascular endothelial cells , 1996, The Journal of experimental medicine.

[69]  E. Azevêdo,et al.  Familial aggregation of Leishmania chagasi infection in northeastern Brazil. , 1995, The American journal of tropical medicine and hygiene.

[70]  E. Cesarman,et al.  Identification of herpesvirus-like DNA sequences in AIDS-associated Kaposi's sarcoma. , 1994, Science.

[71]  S. Zurrida,et al.  Juvenile classic Kaposi's sarcoma: a report of two cases, one with family history. , 1994, Pediatric hematology and oncology.

[72]  A. Dalgleish,et al.  Kaposi's sarcoma. , 1991, British Journal of Cancer.

[73]  U. Ertem,et al.  Aggressive Kaposi's sarcoma in children: a case report. , 1989, The Turkish journal of pediatrics.

[74]  C. Bosman,et al.  Primary kaposi's sarcoma of the lymph node in children , 1988, Cancer.

[75]  I. Magrath,et al.  Childhood Kaposi's sarcoma: clinical features and therapy. , 1976, British Journal of Cancer.

[76]  A. deScoville [Kaposi's sarcoma]. , 1973 .

[77]  M. Pike,et al.  Kaposi's Sarcoma in Uganda: Geographic and Ethnic Distribution , 1972, British Journal of Cancer.

[78]  A. Stout,et al.  Kaposi's sarcoma in infants and children , 1960, Cancer.

[79]  Kaposi,et al.  Idiopathisches multiples Pigmentsarkom der Haut , 1872, Archiv für Dermatologie und Syphilis.

[80]  S. Henikoff,et al.  Predicting the effects of coding non-synonymous variants on protein function using the SIFT algorithm , 2009, Nature Protocols.

[81]  Claude-Alain H. Roten,et al.  Fast and accurate short read alignment with Burrows–Wheeler transform , 2009, Bioinform..

[82]  J. Casanova,et al.  HHV-8-associated Kaposi sarcoma in a child with IFNgammaR1 deficiency. , 2004, The Journal of pediatrics.

[83]  G. Abecasis,et al.  Merlin—rapid analysis of dense genetic maps using sparse gene flow trees , 2002, Nature Genetics.

[84]  E. Zijlstra,et al.  Epidemiology and clinical manifestations of Leishmania donovani infection in two villages in an endemic area in eastern Sudan , 2001 .

[85]  P Jensen,et al.  Skin cancer in kidney and heart transplant recipients and different long-term immunosuppressive therapy regimens. , 1999, Journal of the American Academy of Dermatology.